MedTrace Logo

Chest Imaging, Breath, and Biomarkers in a Screening Trial

NCT01663155 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1424

Last updated 2017-05-18

No results posted yet for this study

Summary

The investigators would like to see if lung cancer screening with chest x-rays,computer aided detection (CAD)and a lose dose CT scan can detect lung cancer in early stages when it is more responsive to treatment. The investigators would also like to see if early detection will reduce the incidence of symptomatic advanced lung cancer compared to no screening in former and current smokers with or without a family history of lung cancer who are 40-75 years old.

Conditions

Interventions

DEVICE

chest x-ray with or without CAD, lose dose CT scan

PA view, low dose CT scan

Sponsors & Collaborators

  • The Cleveland Clinic

    lead OTHER

Principal Investigators

  • Micheal Phillips, M.D. · The Cleveland Clinic

  • Moulay Meziane, MD · Chair of Thoracic Imaging

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2014-05-31
Completion
2014-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01663155 on ClinicalTrials.gov